[Relation between limiting the size of myocardial infarct and heart function improvement].
D000818:Animals; D005260:Female; D006321:Heart / Q000503:physiopathology*; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D051381:Rats; D011919:Rats, Inbred Strains; D064586:Selenic Acid; D012643:Selenium / Q000627:therapeutic use; D018036:Selenium Compounds; D012991:Solanaceous Alkaloids / Q000627:therapeutic use
D018036:Selenium Compounds; D012991:Solanaceous Alkaloids; C003922:anisodamine; D006821:Hyaluronoglucosaminidase; D012643:Selenium; D064586:Selenic Acid